Evonik has officially begun construction of its $220 million global-scale production facility for pharmaceutical specialty lipids in Lafayette, Indiana, in the United States. The new facility is expected to secure the industry’s access to critical excipients needed for mRNA vaccines and other nucleic acid therapies. T…
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. This will be the Company’s first mRNA manufacturing facility in Africa. In part…
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its c…
Dozee, India’s first contactless Remote Patient Monitoring (RPM) & artificial intelligence (AI)-based Early Warning System (EWS) has raised $6 Million as part of its Series A2 funding. The round saw the infusion of funds from Dozee’s existing investor base consisting of Prime Venture Partners, 3one4 Capital, Your…
Hong Kong-based startup Insilico Medicine has announced the opening of the Insilico Medicine Generative Artificial Intelligence (AI) and Quantum Computing Research and Development Centre in Abu Dhabi, the region’s largest AI-powered biotechnology research centre.
Page 59 of 59